StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Skinvisible's EV/EBITDA was 1.7× on Jan 31, 2023, against 9.4× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 20231.7×+0.1
2022Dec 30, 20221.6×−13.4
2021Dec 31, 202115.0×–

More Skinvisible figures

See a number that looks wrong?